Somatic HOXB13 Expression Correlates with Metastatic Progression in Men with Localized Prostate Cancer Following Radical Prostatectomy
- 12 June 2020
- journal article
- research article
- Published by Elsevier in European Urology Oncology
- Vol. 4 (6) , 955-962
Abstract
No abstract availableKeywords
Funding Information
- Prostate Cancer Foundation
- National Institutes of Health (5U01CA196390)
This publication has 22 references indexed in Scilit:
- Prevalence of the HOXB13 G84E mutation in Danish men undergoing radical prostatectomy and its correlations with prostate cancer risk and aggressivenessBJU International, 2016
- Tissue-based Genomics Augments Post-prostatectomy Risk Stratification in a Natural History Cohort of Intermediate- and High-Risk MenEuropean Urology, 2016
- The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesisNature Genetics, 2015
- Prevalence of theHOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomesAnnals of Oncology, 2015
- MEIS1 functions as a potential AR negative regulatorExperimental Cell Research, 2014
- The Cancer Genome Atlas Pan-Cancer analysis projectNature Genetics, 2013
- Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical ProstatectomyPLOS ONE, 2013
- The Homeodomain Protein HOXB13 Regulates the Cellular Response to AndrogensMolecular Cell, 2009
- HOXB13 promotes ovarian cancer progressionProceedings of the National Academy of Sciences, 2007
- HOXB13-to-IL17BR Expression Ratio Is Related With Tumor Aggressiveness and Response to Tamoxifen of Recurrent Breast Cancer: A Retrospective StudyJournal of Clinical Oncology, 2007